The diagnosis of CD-20 negative lymphomas requires pathologists to use a comprehensive panel of markers in order to identify B-cell lineage and reflect various stages of B-cell differentiation, including staining for CD79a, CD19, and PAX5 [16]. Here, MS4A1 is linked to lymphoma.